Tavira Therapeutics is a spin-off from KU Leuven developing a modular next-generation AAV capsid platform, with the goal of enhancing tissue-specific transgene delivery for gene therapy
Company Details
- Employees
- 9
- Founded
- -
- Address
- Leuven, 3001, Be
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.taviratx.com
- HQ
- Leuven
Tavira Therapeutics Questions
Tavira Therapeutics's website is http://www.taviratx.com
Tavira Therapeutics's LinkedIn profile is https://be.linkedin.com/company/tavira-therapeutics
Tavira Therapeutics has
9 employees.
View email and phone details for 9
employees at Tavira Therapeutics.
Tavira Therapeutics's industry is
Biotechnology Research
Tavira Therapeutics's top competitors are
Biotope By Vib,
Amyl Therapeutics,
Astrivax Therapeutics,
Trellis,
Biotalys,
Flindr Therapeutics,
Zymofix,
Montis Biosciences,
General Inception,
Benno Therapeutics.
Tavira Therapeutics's categories are Biotechnology Research
Tavira Therapeutics's founding year is 2023
